Photodynamic Therapy System
Higher-grade cervical dysplasia (CIN2 and CIN3)
Key Facts
About Amplexd Therapeutics
Amplexd Therapeutics is a private, pre-revenue biotech founded in 2020 and based in San Diego, CA. The company is focused exclusively on developing novel, non-invasive treatments for cervical dysplasia (CIN), the precursor to cervical cancer, using a combination of topical drug delivery and a proprietary cold-light photodynamic therapy device. Led by a co-founding team with deep expertise in pharmacology, product development, and medical device engineering, Amplexd aims to commercialize treatments that could reduce the need for surgical interventions like LEEP and cone biopsy. Its pipeline consists of two core programs targeting different grades of dysplasia, both currently in the pre-clinical development stage.
View full company profile